LUV
45
5
BBY
41
-2
MET
63
2
EQR
53
2
LEG
36
3
URI
53
4
PLD
32
-5
DD
33
3
JNJ
60
-2
HBAN
74
4
PBI
48
5
CTSH
49
4
DTE
45
2
AVGO
35
7
FAST
57
-2
ACN
25
3
PSX
37
3
M
20
2
ORCL
49
3
CSCO
48
-8
LUV
45
5
BBY
41
-2
MET
63
2
EQR
53
2
LEG
36
3
URI
53
4
PLD
32
-5
DD
33
3
JNJ
60
-2
HBAN
74
4
PBI
48
5
CTSH
49
4
DTE
45
2
AVGO
35
7
FAST
57
-2
ACN
25
3
PSX
37
3
M
20
2
ORCL
49
3
CSCO
48
-8
Financhill
Sell
45

BPMC Quote, Financials, Valuation and Earnings

Last price:
$86.05
Seasonality move :
7.76%
Day range:
$84.90 - $86.84
52-week range:
$73.04 - $121.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.69x
P/B ratio:
18.36x
Volume:
699K
Avg. volume:
1.1M
1-year change:
-6.69%
Market cap:
$5.5B
Revenue:
$508.8M
EPS (TTM):
-$1.08

Blueprint Medicines SEC Filings

Company Filed Form Type Description
BPMC
Blueprint Medicines
 10/26/2023 10-Q 10-Q filing on 10/26/2023 View Form
BPMC
Blueprint Medicines
 08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
BPMC
Blueprint Medicines
 05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
BPMC
Blueprint Medicines
 11/01/2022 10-Q 10-Q filing on 11/01/2022 View Form
BPMC
Blueprint Medicines
 08/02/2022 10-Q 10-Q filing on 08/02/2022 View Form
BPMC
Blueprint Medicines
 05/03/2022 10-Q 10-Q filing on 05/03/2022 View Form
BPMC
Blueprint Medicines
 10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
BPMC
Blueprint Medicines
 07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
BPMC
Blueprint Medicines
 04/29/2021 10-Q 10-Q filing on 04/29/2021 View Form
BPMC
Blueprint Medicines
 10/29/2020 10-Q 10-Q filing on 10/29/2020 View Form
BPMC
Blueprint Medicines
 07/31/2020 10-Q 10-Q filing on 07/31/2020 View Form
BPMC
Blueprint Medicines
 07/30/2020 10-Q 10-Q filing on 07/30/2020 View Form
BPMC
Blueprint Medicines
 05/06/2020 10-Q 10-Q filing on 05/06/2020 View Form
BPMC
Blueprint Medicines
 02/13/2020 10-K 10-K filing on 02/13/2020 View Form
BPMC
Blueprint Medicines
 11/05/2019 10-Q 10-Q filing on 11/05/2019 View Form
BPMC
Blueprint Medicines
 08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
BPMC
Blueprint Medicines
 05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
BPMC
Blueprint Medicines
 02/26/2019 10-K 10-K filing on 02/26/2019 View Form
BPMC
Blueprint Medicines
 10/30/2018 10-Q 10-Q filing on 10/30/2018 View Form
BPMC
Blueprint Medicines
 08/01/2018 10-Q 10-Q filing on 08/01/2018 View Form
BPMC
Blueprint Medicines
 08/01/2018 10-K 10-K filing on 08/01/2018 View Form
BPMC
Blueprint Medicines
 05/02/2018 10-Q 10-Q filing on 05/02/2018 View Form
BPMC
Blueprint Medicines
 02/21/2018 10-K 10-K filing on 02/21/2018 View Form
BPMC
Blueprint Medicines
 10/31/2017 10-Q 10-Q filing on 10/31/2017 View Form
BPMC
Blueprint Medicines
 08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
BPMC
Blueprint Medicines
 05/03/2017 10-Q 10-Q filing on 05/03/2017 View Form
BPMC
Blueprint Medicines
 03/09/2017 10-K 10-K filing on 03/09/2017 View Form
BPMC
Blueprint Medicines
 11/10/2016 10-Q 10-Q filing on 11/10/2016 View Form
BPMC
Blueprint Medicines
 08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
BPMC
Blueprint Medicines
 07/22/2016 10-Q 10-Q filing on 07/22/2016 View Form
BPMC
Blueprint Medicines
 05/10/2016 10-Q 10-Q filing on 05/10/2016 View Form
BPMC
Blueprint Medicines
 03/11/2016 10-K 10-K filing on 03/11/2016 View Form
BPMC
Blueprint Medicines
 11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
BPMC
Blueprint Medicines
 08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form
BPMC
Blueprint Medicines
 06/11/2015 10-Q 10-Q filing on 06/11/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get BPMC Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

BPMC
Sector
P/E ratio
--
23.76x
PEG ratio
--
0.00x
P/B ratio
18.36x
1.63x
Price / LTM sales
10.69x
1.62x

Growth Metrics

BPMC
Sector
Revenue growth
103.41%
6.38%
Earnings growth
--
8.33%
Revenue (5-year growth)
50.22%
8.19%
Earnings forecast
-$0.44
-$0.20

Profitability

BPMC
Sector
Profitability FY 2024
$488.7M
$54.6M
Return on invested capital
-11.14%
-14.78%
Return on assets
-5.92%
-11.85%
Return on equity
-24.43%
-17.25%

Earnings Date

Last Earnings Date
Feb
13
Next Earnings Date
May
2
Estimated Next Earnings Date
May
15

Balance Sheet

BPMC
Sector
Total cash
$615.5M
$40.8M
Short term investments
$513.5M
$35.9M
Total assets
$1.2B
$122.4M
Long term debt
$387M
$9.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

Should You Buy Alibaba Stock Despite the Risks?
Should You Buy Alibaba Stock Despite the Risks?

Markets rebounded slightly after U.S. President Donald Trump announced a…

Read article
Why Is Intel Struggling Against AMD?
Why Is Intel Struggling Against AMD?

Due to its disappointing reports, so-so management, and lack of…

Read article
Will PayPal Stock Recover or Keep Sliding?
Will PayPal Stock Recover or Keep Sliding?

Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…

Read article

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy or Sell?
Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Buy or Sell?
Sell
49
Is NVDA Stock a Buy?

Market Cap: $2.5T
P/E Ratio: 35x

Buy or Sell?

Alerts

Buy
71
PEGA alert for Apr 24

Pegasystems [PEGA] is up 3.13% over the past day.

Buy or Sell?
Buy
67
SMMT alert for Apr 24

Summit Therapeutics [SMMT] is up 10.38% over the past day.

Buy or Sell?
Sell
36
ENPH alert for Apr 25

Enphase Energy [ENPH] is up 1.44% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas